findmyKOL

Mark Thel, MD

Basic profile

Interventional Cardiology

ORCIDNPI
RegionChattanooga, TN · SoutheastSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Mark Thel is a Cardiology physician. OpenAlex indexes 12 publications with 458 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
12publications

Distinct works indexed by OpenAlex, matched via ORCID.

458citations

Total citations across indexed works.

6h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
22companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2501 Citico Ave
Chattanooga, TN 374041127

Telephone

423-697-2000

Registry record last updated 12 Sept 2019.

View the NPPES registry record

Industry payments

22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    80.9%
    Statin18.7%
    Rosuvastatin Calcium63%Atorvastatin Calcium32%Simvastatin3%Pravastatin Sodium2%
    Part D<11 patients
    Beta blocker15.8%
    Carvedilol46%Metoprolol Succinate28%Metoprolol Tartrate17%Labetalol Hcl4%Sotalol4%Atenolol1%Propranolol Hcl Er1%
    Part D<11 patients

    + 17 more classes in this area

  • Blood & clotting

    14.4%
    Factor Xa inhibitor9.9%
    Eliquis89%Xarelto11%
    Part D203 patients
    P2Y12 inhibitor2.6%
    Clopidogrel96%Prasugrel Hcl5%
    Part D<11 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    4.5%
    Potassium supplement4.1%
    Potassium Chloride96%Klor-Con M204%
    Part D<11 patients
    Proton pump inhibitor0.3%
    Pantoprazole Sodium100%
    Part D13 patients

    + 1 more class in this area

Where care is delivered (Part B)24.9% facility · 75.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”